Ortho-tag Welcomes Christos Monovoukas as Chief Development Officer

We're thrilled to announce the appointment of Christos Monovoukas as our new Chief Development Officer! Christos will also continue to hold his seat on our board of directors.

Christos Monovoukas, Chief Development Officer

With his profound expertise in identifying strategic growth opportunities and spearheading product innovation, Christos will be instrumental in propelling Ortho-tag's mission forward.

Christos brings an impressive two decades of extensive experience within the medical device industry, marked by a stellar track record in business development, corporate strategy, mergers & acquisitions, and venture investing. His distinguished career includes impactful leadership roles at renowned companies such as Zimmer Biomet, Olympus Corporation, Evolus, Smith & Nephew, and Pharos, LLC. He holds an MBA from Harvard University and an M.S. in Mechanical Engineering from Columbia University.

At Ortho-tag, we're dedicated to revolutionizing medical implants with in-body smart sensors for diagnosis, monitoring, and therapeutic drug delivery. We leverage our proprietary technologies for wireless in-body communication, real-time data exchange, and nanodiagnostic functionality.

We are incredibly excited to have Christos on board as we continue to push the boundaries of smart implant technology and deliver solutions that enhance patient outcomes. Please join us in extending a warm welcome to Christos!